StockData
SRTANasdaqServices-Health ServicesFiscal year ends December 31

Strata Critical Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$4.54+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$391.41M
P/E (TTM)
8.9
Dividend yield
–

About Strata Critical Medical

Services-Health Services, SIC 8000

Strata Critical Medical, Inc. provides time-critical logistics and specialized clinical services to the healthcare sector in the United States. Through its Logistics segment, operating under the Trinity brand, the organization arranges air and ground transport for donor organs, surgical personnel, medical equipment, and biological samples, while also offering donor organ placement coordination. Through its Clinical segment, marketed under the Keystone brand, the company provides surgical organ recovery, organ preservation, normothermic regional perfusion, and cardiac perfusion services, alongside clinical staffing and medical equipment rentals. Its services are directly contracted by organ procurement organizations, transplant centers, and cardiovascular surgery hospitals.

The company operates nationwide across the United States. Its operations are supported by a workforce of 601 domestic employees, consisting of 327 full-time and 274 part-time personnel distributed across logistics, clinical, and administrative functions. Its ground logistics network utilizes hubs situated near customer locations, complemented by a fleet of ten company-owned fixed-wing aircraft alongside third-party transportation operators. Strata Critical Medical maintains its headquarters functions in the United States.

Summary of the business section of Strata Critical Medical's latest annual report, written by StockData.

Company profile

Company

Legal name
Strata Critical Medical, Inc.
Founded
2019
Headquarters
New York, NY
Address
666 Third Avenue, 25th Floor 10017
Phone
(212) 967-1009
Employees
601, Dec 31, 2025
Industry
Services-Health Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, New York, New York

Stock & identifiers

Ticker
SRTA
Exchange
Nasdaq
IPO date
Sep 13, 2019
Shares outstanding
88M, Jul 28, 2026
Public float
$263.90M, Jun 30, 2025
Filer category
Accelerated filer
SEC CIK
1779128
CUSIP
092667104
ISIN
US0926671043
EIN
84-1890381

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
William A. HeyburnCo-CEO and CFO, Director1,856,206
Melissa M. TomkielCo-CEO and General Counsel, Director2,244,475
Scott M. WunschCEO, Logistics1,046,030
Amir CohenChief Accounting Officer177,154
Louis R. VerdettoCEO, Clinical Services1,260,328
Reginald LoveDirector146,481
Andrew LauckDirector170,902
Robert S. WiesenthalDirector5,325,896
William L. Cook IIIDirector97,671
Edward M. PhilipDirector265,078
Susan M. LyneDirector187,185
Eric AffeldtDirector581,214
Kenneth B. LererDirector196,859
John BorthwickDirector203,977

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Melissa MTomkiel
$5.61M$4.10M$1.65M$134–
FY2025
Robert Wiesenthal
$5.05M$6.03M$1.65M$134–
FY2025
William AHeyburn
$5.33M$3.67M$1.65M$134–
FY2024
Melissa MTomkiel
$0$0$5.77M$119–
FY2024
Robert Wiesenthal
$9.56M$4.32M$5.77M$119–
FY2024
William AHeyburn
$0$0$5.77M$119–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, the Company employed 601 employees, all of whom were located across the United States.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 6, 2026DelistingNotice of delisting from exchange (Form 25)
Dec 2, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 16, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 29, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 18, 2025Name changeName changed from Blade Air Mobility, Inc. to Strata Critical Medical, Inc.
Mar 22, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
May 18, 2021Late filingNotification of late filing
May 17, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 13, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 7, 2021DelistingNotice of delisting from exchange (Form 25)
May 7, 2021Name changeName changed from Experience Investment Corp. to Blade Air Mobility, Inc.
Jan 29, 2021MergerRegistration of securities for a merger or exchange offer (S-4)
Sep 13, 2019IPOInitial public offering priced (424B4 prospectus)
Sep 12, 2019ListingRegistration of securities on an exchange (Form 8-A)